January 2010 in “Springer eBooks” This review discusses the psychological and social challenges of hirsutism in women and suggests that eflornithine cream may offer a small quality of life improvement for affected individuals, though with limited evidence.
February 2009 in “Journal of The American Academy of Dermatology” Atopic dermatitis significantly lowers the quality of life for infants and their families.
January 2009 in “Repositório Científico do Instituto Politécnico de Viseu (Instituto Politécnico de Viseu)” This case study found that a skin lesion in a Samoyed dog did not match any single known follicular cyst or neoplasm type described in the literature.
February 2008 in “Expert Review of Dermatology” This review explores how seborrheic dermatitis impacts patients' quality of life but does not present new research findings; it highlights a need for further studies on influencing factors.
March 2005 in “Journal of the American Academy of Dermatology” This study found that hair loss impairs quality of life differently for men and women in France, affecting men's physical health and women's mental health more significantly.
November 2004 in “Qucosa (Saxon State and University Library Dresden)” This study developed analytical methods to better understand hair treatment with cosmetic formulations, revealing that active agents primarily adsorb on the hair surface during short washes.
This reference compilation details potential adverse skin reactions and other side effects associated with the antihypertensive drug Quinazil, including rare cases of skin angioedema and other dermatological reactions.
July 1996 in “Annals of Internal Medicine” This correspondence reported significant variability between quantitative PCR and bDNA assays for measuring Hepatitis C virus RNA in high-titer specimens, challenging the reliability of the Chiron assay.
November 1995 in “Journal of Pediatric Health Care” Most hair loss in kids and teens is due to common conditions, and hair usually grows back within 6 months.
This study suggests that holes found in mature hair fibers may be linked to daily hair care actions and the removal of extractable substances.
This abstract provides no study findings; it outlines website features and permissions for accessing JAMA Network content.
This entry is a placeholder containing only website navigation details and reports no research findings.
February 1960 in “Journal of the American Medical Association” Treatments for hair loss include estrogen therapy and special shampoos.
May 1948 in “Journal of the American Medical Association” The reply suggests checking for false positive or asymptomatic syphilis and using penicillin for treatment if necessary.
February 1938 in “Journal of the American Medical Association” This abstract contains no research results but appears to be a web navigation or user interface message.
January 2022 in “Social Science Research Network” This study demonstrates that a newly developed nanocomposite microneedle patch, releasing copper and zinc ions along with quercetin, effectively promotes hair follicle regeneration in androgenic alopecia by targeting various pathophysiological aspects of hair loss.
December 2022 in “Clinical, Cosmetic and Investigational Dermatology” This study found that patients with androgenetic alopecia, especially those who are young, less educated, and single, experience significantly reduced health-related quality of life.
November 2022 in “Skin appendage disorders” In this study, the authors successfully translated, culturally adapted, and validated the Women's Androgenetic Alopecia Quality of Life questionnaire into Spanish, demonstrating it as a reliable tool for assessing female pattern hair loss.
August 2022 in “Nutrients” This ex vivo study found that hair follicles in female pattern hair loss exhibited nutrient insufficiency and dormant metabolism, but maintained nutrient uptake capability, suggesting potential benefits of nutritional supplementation as an adjunct therapy.
July 2022 in “Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria” This study found that androgenetic alopecia significantly impairs quality of life among Nigerian patients, especially in areas like emotions, stigmatization, and self-confidence, highlighting the importance of psychosocial support.
April 2022 in “Journal of the Medical Sciences” This study found a significant relationship between the severity of androgenetic alopecia in men and a negative impact on their quality of life.
This study developed a method using ultra-performance liquid chromatography and mass spectrometry to detect illegal substances in hair loss prevention cosmetics, revealing that some products contained high levels of minoxidil and finasteride, posing safety risks.
December 2021 in “Journal of BP Koirala Institute of Health Sciences” This study found that male patients with androgenetic alopecia experienced more emotional impact than symptomatic or functional effects, highlighting the importance of assessing quality of life in these individuals.
December 2021 in “Acta dermato-venereologica” This study developed a deep learning framework and quantitative model that accurately predict basic and specific classification in male androgenetic alopecia by analyzing trichoscopic images.
May 2021 in “The Journal of clinical and aesthetic dermatology” This study found that women with androgenetic alopecia using 5% minoxidil daily reported high satisfaction and improved quality of life, despite the continued impact of hair loss on daily habits and social life.
March 2021 in “Journal of The European Academy of Dermatology and Venereology” Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.
March 2020 in “Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï” This study developed quality control methods for the "Flavosterol" emulgel, which met the required quality standards and is intended for the prevention and treatment of androgenetic alopecia.
October 2019 in “International journal of clinical & experimental dermatology” This study found that female pattern hair loss significantly reduces quality of life, particularly among younger patients, those with longer disease duration, and individuals with diagnosed mental health issues.
October 2019 in “Our Dermatology Online” In this study, researchers reported that androgenetic alopecia is associated with significantly decreased quality of life, particularly impacting younger patients and those with severe or long-standing hair loss.
April 2017 in “Journal of Pakistan Association of Dermatology” This study found that female pattern hair loss significantly impacts quality of life, suggesting that psychological support may enhance treatment adherence.